Odyssey Therapeutics, Inc. (NASDAQ:ODTX – Get Free Report) major shareholder Sr One Capital Management, Llc purchased 555,555 shares of the firm’s stock in a transaction that occurred on Monday, May 11th. The stock was bought at an average cost of $18.00 per share, with a total value of $9,999,990.00. Following the completion of the purchase, the insider owned 1,831,383 shares of the company’s stock, valued at $32,964,894. This represents a 43.54% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Major shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.
Sr One Capital Management, Llc also recently made the following trade(s):
- On Monday, May 11th, Sr One Capital Management, Llc sold 1,780 shares of Odyssey Therapeutics stock. The shares were sold at an average price of $18.00, for a total transaction of $32,040.00.
Odyssey Therapeutics Price Performance
NASDAQ ODTX traded up $1.03 during trading hours on Monday, reaching $17.45. 426,992 shares of the company’s stock traded hands. Odyssey Therapeutics, Inc. has a 52-week low of $15.35 and a 52-week high of $20.30.
Featured Stories
- Five stocks we like better than Odyssey Therapeutics
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
- MercadoLibre Boldly Invests in Growth: Discount Deepens
Receive News & Ratings for Odyssey Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Odyssey Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
